| 1 |
Ankrah AO, Glaudemans AWJM, Maes A, et al. Tuberculosis[J]. Semin Nucl Med, 2018, 48(2): 108-130.
|
| 2 |
Meintjes G, Brust JCM, Nuttall J, et al. Management of active tuberculosis in adults with HIV[J]. Lancet HIV, 2019, 6(7): 463-474.
|
| 3 |
Halliday A, Masonou T, Tolosa-Wright M, et al. Immunodiagnosis of active tuberculosis[J]. Expert Rev Respir Med, 2019, 13(6): 521-532.
|
| 4 |
中华医学会结核病学分会临床检验专业委员会. 结核病病原学分子诊断专家共识[J]. 中华结核和呼吸杂志，2018, 41(9): 688-695.
|
| 5 |
任成山，林 辉，杨仕明. 结核病的流行特征与耐多药的窘迫及其策略[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 269-274.
|
| 6 |
Cardona PJ. Pathogenesis of tuberculosis and other mycobacteriosis[J]. Enferm Infecc Microbiol Clin, 2018, 36(1): 38-46.
|
| 7 |
Tu Phan LM, Tufa LT, Kim HJ, et al. Trends in diagnosis for active tuberculosis using nanomaterials[J]. Curr Med Chem, 2019, 26(11): 1946-1959.
|
| 8 |
Leisching G, Wiid I, Baker B. OAS1, 2, and 3: Significance during active tuberculosis[J]. J Infect Dis, 2018, 217(10): 1517-1521.
|
| 9 |
Caraballo Cortes K, Osuch S, Perlejewski K, et al. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+ CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus[J]. J Viral Hepat, 2019, 26(8): 942-950.
|
| 10 |
Huang P, Lv C, Zhang C, et al. Expression and significance of T-cell immunoglobulin mucin molecule 3 and its ligand galectin-9 in patients with adenomyosis[J]. Gynecol Endocrinol, 2020, 36(7): 605-610.
|
| 11 |
Kim KJ, Lee HW, Seong J. Combination therapy with anti-T-cell immunoglobulin and mucin-domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2021, 36(5): 1357-1365.
|
| 12 |
中华医学会. 肺结核基层诊疗指南(2018年)[J]. 中华全科医师杂志，2019, 18(8): 709-717.
|
| 13 |
Tu Phan LM, Tufa LT, Kim HJ, et al. Trends in diagnosis for active tuberculosis using nanomaterials[J]. Curr Med Chem, 2019, 26(11): 1946-1959.
|
| 14 |
侯志强，齐亚萌. 克拉维酸钾配伍阿莫西林治疗对老年肺结核外周血自然杀伤细胞表面受体及肺组织中B、T淋巴细胞衰减子表达的影响[J]. 中国老年学杂志，2018, 38(12): 2907-2910.
|
| 15 |
La Manna MP, Orlando V, Prezzemolo T, et al. HLA-E-restricted CD8+ T lymphocytes efficiently control mycobacterium tuberculosis and HIV-1 coinfection[J]. Am J Respir Cell Mol Biol, 2020, 62(4): 430-439.
|
| 16 |
Datar I, Sanmamed MF, Wang J, et al. Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non-small cell lung cancer using spatially resolved and multiparametric single-cell analysis[J]. Clin Cancer Res, 2019, 25(15): 4663-4673.
|
| 17 |
代 娇，宋秋玲，段慧英，等. 活动性肺结核患者Tim-3/Galectin-9的表达变化及其与巨噬细胞相关细胞因子的相关性[J]. 实用医学杂志，2019, 35(7): 95-99.
|
| 18 |
石卫武，董飞波，陈锦春，等. 结核感染T细胞斑点试验在结核病中的应用价值探讨[J]. 中国卫生检验杂志，2019, 1(17): 2086-2088.
|
| 19 |
管立学，李海波，褚锦锦，等. 外周血结核感染T细胞斑点试验对活动性结核的诊断价值[J]. 中华医院感染学杂志，2019, 29(3): 340-345.
|
| 20 |
孙宇峰，张明新，隋文君，等. γ-干扰素释放试验联合肿瘤标志物CA-125在活动性肺结核诊断中的应用[J]. 中华医学杂志，2019, 99(8): 599-604.
|
| 21 |
陈 晶，张裕娴，芮勇宇. γ干扰素释放试验在结核病诊断中的应用价值[J]. 中国感染与化疗杂志，2020, 20(3): 28-31.
|
| 22 |
许敏殷，刘 银，刘丽蓉，等. γ干扰素释放试验联合IL-6检测对活动性肺结核的诊断价值[J]. 中国现代医学杂志，2020, 30(10): 18-21.
|
| 23 |
李海军，刘 瑜，寇 夕. 老年活动性肺结核患者血清25-(OH)D_3,炎症因子水平的变化及临床意义[J]. 海南医学，2020, 31(22): 39-42.
|
| 24 |
郎 清，周家青，董先成，等. 肺结核病人血清IL-10，TNF-α及IgE表达及临床意义[J]. 内蒙古医学院学报，2019, 41(6): 567-570.
|